First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
Data analysis by Aarthi Thiruvengadam Over the first few months of the COVID-19 pandemic, the workers’ compensation industry has gone thro
Brand name medications are often scrutinized by the workers’ compensation industry for their high cost.
Part Two: Evaluating In-Network and Out-of-Network Trends In this final post related to our in-network and out-of-network analysis we
Taking a multi-disciplinary approach to ongoing pain management and opioid recovery
Following up on comments received at their June 25, 2020, hearing, the Industrial Commission of Arizona released a revised version of their draft f
Over the last decade, the insurance industry has undergone dramatic changes that have catapulted it to the forefront of the American consciousness,